Skip to content

Goodwill at other companies

Myriad Genetics logo
Myriad GeneticsMYGN
$47.1M-83.5%
Labcorp Holdings logo
Labcorp HoldingsLH
$6.96B+8.3%
Quest Diagnostics logo
Quest DiagnosticsDGX
$9.12B+3.1%
NeoGenomics logo
NeoGenomicsNEO
$524M+0.2%
Illumina logo
IlluminaILMN
$1.28B+15.4%
CareDx logo
CareDxCDNA
$40.34M0.0%

Other financials

Income statement

See full
Revenue$696.6M+38.8%
Operating income-$93.5M-18.1%
Net income-$85.1M-27.1%
EPS (diluted)-$0.60-20.0%

Balance sheet

See full
Cash & equivalents$1.1B+11.7%
Total debt$240.1M+22.7%
Total equity$1.8B+43.1%
Total assets$2.6B+50.9%

Cash flow

See full
Operating cash flow$40.2M-9.6%
CapEx$22.1M+1.5%
Free cash flow$18.0M-20.3%

Valuation

See full
Market cap$38.88B+74.2%
Enterprise value$38.03B+76.7%
P/S15.5×+4.2×

Profitability

See full
Gross margin42.9%
Operating margin-13%+0.6pp
Net margin-14.6%+0.6pp
FCF margin4.2%-0.5pp

Returns & leverage

See full
Return on equity-29%+4.1pp
Debt / equity0.1×0.0×
Current ratio-0.9×

Where this comes from

Reported directly by Natera, Inc. in its filing.

Tagged under the XBRL concept us-gaap:Goodwill.

The official record: Natera, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Natera, Inc.'s goodwill.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Natera, Inc.'s goodwill?
Natera, Inc. (NTRA) reported goodwill of $140.86M in Q1 2026.
What does goodwill mean?
The excess of acquisition cost over the fair value of net identifiable assets acquired — representing brand value, customer relationships, and synergies from past M&A.